Specifically, JMJD3 has been shown to decrease the occupations of H3K27me3 at the β-catenin promoter in activated cardiac fibroblasts, raising the expression of genes related to fibrosis and ultimately contributing to the advancement of myocardial fibrosis. The gene discussed is KDM6B; the disease is Myocardial fibrosis.